Clinical Trials Browser

Phase 3 × Completed × bermekimab × Clear all

NCT02138422 2021-03-01

A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer

Phase 3 Completed

Gastrointestinal

Colorectal Neoplasms